Live GMP
Aureate Tradde Ltd GMP ₹0 Hexagon Nutrition Ltd GMP ₹3+6.67% Genxai Analytics Ltd GMP ₹0 Vahh Chemicals Ltd GMP ₹0 CMR Green Technologies Ltd GMP ₹0 Merritronix Ltd GMP ₹93+62.42% Liotech Industries Ltd. GMP ₹0
Rainbow Children's Medicare Ltd. Logo

Rainbow Children's Medicare Ltd. IPO

Closed Bookbuilding IPO NSE & BSE Fresh Capital-cum-Offer for Sale
← Back to GMP
Issue Price ₹542
GMP
Lot Size 27
Face Value ₹10
Issue Size 29,168,579 shares (aggregating up to ₹1,581 Cr)
Subscription

IPO Timeline

Open Date27-Apr-22
Close Date29-Apr-22
Allotment5-May-22
Refund Initiation6-May-22
Demat Credit9-May-22
UPI Mandate Deadline29-Apr-22
Listing Date10-May-22
Lock-in (30%)4-Jun-22
Lock-in (50%)3-Aug-22

Category-wise Subscription

Shares offered, bid & amount
CategorySub (x)OfferedBid ForAmt (Cr)*
QIB 14,439,009 (49%) ₹78,259 Cr
NII (HNI) 4,331,704 (15%) ₹23,478 Cr
Retail 10,107,308 (35%) ₹54,782 Cr
Employee 300,000 (1%) ₹163 Cr
Σ  Total29,178,021 (100%)₹1,581,449 Cr

Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.

Issue Details

Issue Price / Price Band₹542
Face Value₹10
Lot Size27 shares
Issue Size29,168,579 shares (aggregating up to ₹1,581 Cr)
Issue TypeBookbuilding IPO
Listing ExchangeNSE & BSE
Sale TypeFresh Capital-cum-Offer for Sale
Script Code
Fresh Issue5,167,679 shares (aggregating up to ₹280 Cr)
Offer for Sale24,000,900 shares of ₹10 (aggregating up to ₹1,301 Cr)
Net Offer to Public
Amount InCrore
Stock Price History · BSE
Loading chart data...
H
L
O
Yahoo Finance · Live

Minimum Investment (Lot-wise)

CategoryLotsSharesAmount (₹)
Retail (Min)127₹14,634
Retail (Max)13351₹190,242
S-HNI (Min)14378₹204,876
B-HNI (Min)671,809₹980,478
Retail1 lot(s)27 shares₹14,634
S-HNI14 lot(s)378 shares₹204,876
B-HNI69 lot(s)1,863 shares₹1,009,746

Shareholding Pattern

Pre-Issue Shareholding96,334,008 shares%
Post-Issue Shareholding101,511,129 shares%
Reserved for Market Maker

Financial Statements Amount in Crore

Metric 31-Dec-21 31-Dec-20 31-Mar-21
Revenue 774 494 660
Profit After Tax 126 39 40
Total Assets 1,240 1,076 1,081

Valuation & Key Ratios

ROE
ROCE
RONW
PAT Margin
EBITDA Margin
Debt/Equity
P/BV
Pre EPS
Post EPS
Pre P/E44
Post P/E

Grey Market Premium (GMP)

Current GMP

GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.

Objects of the Issue

  • 1 Early redemption of NCDs issued by the Company to CDC Emerging Markets Limited (“CDCEML”), one of the Group Companies, in full – 40.00
  • 2 Capital expenditure towards setting up of new hospitals and purchase of medical equipment for such new hospitals – 170.00
  • 3 General corporate purposes – 56.20

Company Overview

Rainbow Children's Medicare Limited operates a multi-speciality pediatric, obstetrics and gynaecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-speciality services, pediatric quaternary care, obstetrics and gynaecology, which includes normal and complex obstetric care, and multidisciplinary fetal care, perinatal genetic and fertility care. Rainbow Children's Medicare operates 14 hospitals and three clinics in six cities, with a total bed capacity of 1,500 beds, as of September 30, 2021. In 1999, the company started its first pediatric speciality hospital in Hyderabad.

Rainbow Children's Medicare Limited operates on a full-time doctor model ensuring that most of the core specialists are available 24/7 which is particularly important for children's emergency, neonatal and pediatric intensive care services. As of September 30, 2021, the company had 602 full-time doctors and 1,686 part-time/visiting doctors.

Competitive Strengths:

  1. Ability to conceptualize, create and operate specialized children's hospitals.
  2. Leading pediatric multi-speciality healthcare chain with strong clinical expertise in managing complex diseases.
  3. Comprehensive perinatal care provider, with synergies between pediatric and obstetrics and gynaecology services.
  4. The hub-and-spoke model provides synergies and ensures better care and access for patients.
  5. Strong track record of growth, and operational and financial performance.
  6. Experienced senior management team with strong institutional shareholder support.

Company Information

Address8-2-120/103/1, Survey No. 403, Banjara Hills, Hyderabad – 500 034 Hyderabad, Telangana